About us

IMIBIC

The Maimonides Biomedical Research Institute of Cordoba (IMIBIC) is a health research institute. It was founded in 2008 based on an agreement between the Regional Ministry of Health, the Regional Ministry of Economy and the University of Cordoba. Another agreement between the founding entities was signed in 2015, to reinforce their commitment to consolidate IMIBIC as a biomedical research center of excellence. In 2011 IMIBIC was accredited as one of the 29 Health Research Institutes by the Spanish National Institute of Health Carlos III (ISCIII). The accreditation was renewed in 2016.

IMIBIC is a multidisciplinary research space where scientists from the academic and health care sectors work together to improve the health of citizens and boost the social and economic development in the province of Cordoba.

IMIBIC is managed by the Foundation for Biomedical Research of Cordoba (FIBICO), founded in 2007.

Mission

Our mission is to develop and promote a scientific and innovative space of multidisciplinary collaboration in which to conduct projects aimed at solving health problems based on precision medicine and science of excellence.

Vision

Our vision is to be a center dedicated to translational research of excellence in precision medicine and innovation, both nationally and internationally.

Values

IMIBIC supports high quality, ethical scientific research based on the principles of healthcare improvement, social commitment, innovation and excellence. These principles are shared and supported by all members of the Institute.

Quality Policy

IMIBIC believes that quality is an essential aspect of the Institute’s activities. Quality must be quantified and therefore measured objectively and evaluated externally by other institutions. To this end, the activities of the Institute are geared to meeting the needs of professionals, patients and other stakeholders by means of an Integrated Quality Management System in accordance with the accreditation scheme of the ISCIII Health Research Institutes.

Research, Development and Innovation Policy

At IMIBIC, innovation means introducing new products, services or organisational processes in the system that permit the effective application of research results and translate them into real benefits for the health of citizens.

Our Research, Development and Innovation Policy is built on the strategic pillars of multidisciplinary collaboration and precision medicine as the foundation of a translational Institute with a national and international scope.

The R&D&I policy is based on a global and cross-cutting approach to ensure only the highest standards of quality. To achieve this aim, we have a R&D&I management system that complies with UNE Standard 166002:2014.